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T
 
he 
 
synthesis, segregation, intracellular transport,
and exocytic export of secretory proteins in eukary-
otic cells is now well understood. Synthesis begins
on free cytosolic ribosomes that subsequently attach to the
ER, resulting in the cotranslational discharge of the na-
scent proteins into the ER lumen. The targeting signals
and the cytosolic and ER membrane components that me-
diate the translocation step have been extensively charac-
terized and reviewed (for example, see 29). The ER lumen
contains a range of resident proteins responsible for modi-
fying newly synthesized polypeptides, and for ensuring
correct folding into the biologically active conformation
(9). Secretion entails transport of the proteins from the
ER, via the Golgi stack and the TGN, to secretory vesicles
that ultimately fuse with the plasma membrane to com-
plete protein export. The secretory pathway was eluci-
dated by Palade and his colleagues (24). Protein transport
between the various compartments of the secretory path-
way is mediated by carrier vesicles that bud from one com-
partment and fuse with the next. Once again, many of the
cellular components that are required for, and that regu-
late, vesicular transport have been identified, and the
mechanisms by which cytoplasmic protein coats drive the
individual transport steps are now emerging (31). It has
been recognized for some time that the secretory pathway
is at least partially reversible. For example, retrograde ve-
sicular transport from the Golgi to the ER is needed to re-
trieve resident ER proteins that have escaped from this
compartment (25), and endocytosis can transport proteins
from the cell surface to the TGN (2), which is the cellular
location where the secretory and endocytic pathways con-
verge (31). ER resident proteins contain a retrieval sig-
nal, the COOH-terminal tetrapeptide Lys-Asp-Glu-Leu
 
(KDEL),
 
1
 
 which binds to a membrane receptor in the 
 
cis
 
-
Golgi region and returns them to the ER. Indeed the
KDEL receptor is capable of retrieving escaped ER resi-
dent proteins from as far along the secretory pathway as
the TGN; an exogenous synthetic peptide with a COOH-
terminal KDEL sequence, which was introduced into the
TGN from the cell surface was subsequently transported
to the ER lumen (20). Recently, it has become apparent
that certain protein toxins follow this same route from the
surface to the ER lumen. To reach their targets in the cy-
tosol of mammalian cells the toxins apparently go one step
further and cross the ER membrane. The emerging exper-
imental evidence in support of this is reviewed here.
 
Toxin Structure and Mode of Action
 
Certain bacteria and plants produce proteins that are able
to enter and kill mammalian cells. These proteins all act by
catalytically modifying essential cellular components so
that their normal function is prevented. In this review, we
focus on a subset of these toxins that act by inhibiting cel-
lular protein synthesis. Other catalytic toxins enter cells by
the same mechanisms, and reference will be made to them
(where appropriate). Bacterial toxins that inhibit protein
synthesis in eukaryotic cells include diphtheria toxin (DT),
 
Pseudomonas
 
 exotoxin A (PE), and Shiga toxin (ST),
whereas the best characterized of a group of related plant
toxins is ricin. DT, PE, and ricin are all synthesized as sin-
gle polypeptide chains but in their functional form they ex-
ist as heterodimers covalently joined by a single disulfide
bond. DT and PE are cleaved into dimers after entering
mammalian cells by the ubiquitous protease furin (7),
whereas ricin is cleaved in the plant cells that produce it
(17). In the heterodimeric toxins, one polypeptide (often
designated the A chain or fragment) is catalytically active
whereas the other (the B chain or fragment) is responsible
for binding the toxin to receptors on the surface of suscep-
tible cells. ST differs in structure from the other toxins de-
scribed here in that the catalytic A chain is associated with
a pentamer of B subunits, the so called AB
 
5
 
 structure pos-
sessed by other bacterial toxins such as cholera toxin and
 
Escherichia coli
 
 heat labile enterotoxin.
DT and PE inhibit protein synthesis by ADP-ribosylat-
ing elongation factor–2 (45), whereas ST and ricin act by
removing a specific adenine residue from a highly con-
served loop present in 28S rRNA (5). Since the toxin sub-
strates are in the cell cytosol, the A chain must enter the
target cell cytosol and retain its biologically active confor-
mation. To enter mammalian cells, the toxins must first
bind to a surface component. Binding can be to a specific
 
protein such as the 
 
a
 
2
 
-macroglobulin receptor (used by
PE) (15) or a heparin-binding epidermal growth factor
(EGF)-like growth factor precursor (used by DT) (21), to
glycolipids such as globotriaosyl ceramide (used by ST)
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(11), or ganglioside G
 
M1
 
 (used by cholera toxin) (44), or to
any appropriate glycoprotein or glycolipid (as in the case
of ricin whose B chain is a galactose-specific lectin) (17).
 
Cell Entry
 
Surface-bound toxin enters cells by endocytosis; the en-
docytic route depends on the nature of the receptor. DT,
for example, appears to enter exclusively via clathrin-
coated pits and vesicles. As such, overexpression of mu-
tant dynamin, which prevents clathrin-dependent endocy-
tosis, protects cells from intoxication by DT (40). Such
cells remain completely sensitive to ricin, however. Nor-
mally ricin uses both clathrin-dependent and -independent
endocytosis, so when the former route is effectively
blocked the latter remains available. The clathrin-inde-
pendent  route used by ricin does not appear to be medi-
ated by caveolae since it is unaffected by treatment with
cholesterol-binding drugs such as nystatin (40). ST appears
to enter cells exclusively via clathrin-dependent endocyto-
sis (33), suggesting that its glycolipid receptor becomes
fixed in coated pits, possibly by interacting with a protein
already anchored there. Both the clathrin-dependent and
the clathrin-independent uptake routes converge in endo-
somes. At this stage the endocytosed toxins fall into two
different behavioral groups: those that translocate into the
cytosol from an endosomal compartment, and those that
do not. Toxins whose A fragment crosses the endosomal
membrane include DT, which has been most thoroughly
studied, and others such as anthrax, tetanus, and botuli-
num toxins. DT translocation depends crucially on the low
pH of the endosomal compartment, which induces a con-
formational change in DT B causing it to insert into the
endosomal membrane and form, or contribute to the for-
mation of, a proteinaceous pore through which the A frag-
ment is able to pass. Further discussion of the DT translo-
cation mechanism can be found elsewhere (37).
Since DT translocation requires low pH, treating cells
with reagents that increase endosomal pH protects them
from intoxication. Conversely, lowering the extracellular
pH to that typically found in endosomes causes surface-
bound DT to directly cross the plasma membrane. Increas-
ing the intracellular pH does not protect cells against
members of the second group of toxins; toxins that do not
translocate from endosomes including PE, ST, and ricin.
Members of this second toxin group must proceed beyond
endosomes to reach the compartment for A chain translo-
cation.
 
Intracellular Transport Beyond Endosomes
 
The trafficking of endocytosed ricin beyond endosomes
was initially followed by electron microscopy (42). In addi-
tion to entering lysosomes or being recycled back to the
cell surface, a significant amount of toxin accumulated in
the TGN. Initially this was interpreted as suggesting that
ricin A chain translocated to the cytosol from the TGN
(43). With hindsight, a critical limitation of this experi-
mental approach was its sensitivity. Whereas it clearly
defined the fate of the bulk of the endocytosed toxin, the
extreme potency of such proteins (entry of just a few mol-
ecules into the cytosol is believed sufficient to kill a cell)
meant that the productive but inefficient trafficking to the
translocation compartment went undetected. One of the
first experimental indications that toxins such as PE, ST,
and ricin might not translocate from the TGN was the
demonstration that treating the cells with brefeldin A
(BFA) protected against these toxins but had no effect on
their susceptibility to DT (50). A careful morphological
study of ricin trafficking in BFA-treated cells showed that
in all lines where protection was seen, the typical BFA-
induced dissembly of the Golgi stack had occurred (32).
Transport of ricin to the TGN was unaffected by BFA
treatment. In contrast, treating MDCK cells with BFA did
not confer protection against ricin nor did it structurally
perturb the Golgi apparatus.
Experiments with PE mutants suggested that PE might
also undergo retrograde transport from the TGN to the
ER, and provided a likely explanation of how this oc-
curred. The last five COOH-terminal residues of the trans-
located PE fragment are Arg-Glu-Asp-Leu-Lys (REDLK).
The effect of mutations in this pentapeptide on the cata-
lytic activity and cytotoxicity of PE were determined. De-
letions or substitutions predicted to prevent interaction
with the KDEL receptor dramatically reduced cytotoxicity
(3). Such changes had no effect on catalytic activity and
apparently cause reduced cytotoxicity by preventing the
mutant forms from reaching the cytosol. Replacing the
wild-type REDLK sequence with KDEL produced a mu-
tant toxin even more cytotoxic than wild-type PE. (36).
The COOH-terminus of the catalytic polypeptide of chol-
era toxin is KDEL, and that of 
 
E. coli
 
 heat labile entero-
toxin is RDEL. Subsequent work has established that chol-
era and 
 
E. coli
 
 heat-labile toxin action are also blocked by
BFA treatment (4). The cytotonic activity of these G pro-
tein–modifying proteins is not absolutely dependent on
the KDEL/RDEL tetrapeptide, although it apparently en-
hances delivery into the cytosol (16). EM studies have vi-
sualized endocytosed ST (34) and cholera toxin (35) in the
ER lumen, and cholera toxin transport from the plasma
membrane to the ER has been described (18). For toxins
that contain KDEL or a KDEL analogue at the COOH-
terminus of the translocated polypeptide, retrograde trans-
port from the TGN to the ER is most probably achieved
by interaction with the KDEL receptor which is now
known to recycle between these compartments (8, 20). Pre-
sumably, after endocytosis, recycling cell surface receptor
delivers a proportion of the toxin to the TGN where recep-
tor–toxin dissociation occurs leaving the free toxin able to
opportunistically interact with the KDEL receptor.
How do toxins such as ST and ricin, which do not pos-
sess KDEL or a related peptide, travel from the TGN to
the ER? That ST can reach the ER lumen is beyond dis-
pute since, as noted above, it has been visualized there.
The effect of BFA treatment suggests that ricin must also
traverse the Golgi stack to reach the ER. This contention
was supported by the finding that addition of the KDEL
retrieval signal to the COOH-terminus of ricin A chain
significantly enhances cytotoxicity (46). It seems likely that
ricin undergoes retrograde transport from the TGN to the
ER by binding to a recycling galactosylated component. Ri-
cin B chain contains two functional galactose-binding sites,
and is itself glycosylated. Because it has a high mannose
oligosaccharide sidechain, ricin is able to intoxicate cells
with mannose receptors, such as macrophages, even when 
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binding to galactosylated surface components is prevented
(38). The effect of abrogating one or other or both B chain
galactose-binding sites on the cytotoxicity of ricin entering
macrophages via the mannose receptor showed that toxin
retaining either of the B chain sugar-binding sites re-
mained cytotoxic, but when both sites were destroyed, tox-
icity was lost (22). The putative recycling galactosylated
component used by ricin for retrograde transport might
itself carry a KDEL retrieval signal, be a transmembrane
glycoprotein with a retrieval signal such as KKXX (12), or
may interact with another molecule that has a retrieval
signal.
 
The ER as the Site of Toxin Translocation
 
Recently the first direct biochemical evidence that en-
docytosed ricin reaches the ER before translocating to the
cytosol has been presented (28). Ricin A chain was modi-
fied to contain a tyrosine sulfation site and overlapping
 
N
 
-glycosylation sites. Mutant A chain was reassociated
with B chain and incubated with cells in the presence of
Na
 
2
35
 
SO
 
4
 
 and the A chain became radiolabeled. This la-
beling identified that proportion of the endocytosed toxin
that had reached the Golgi, and labeling was prevented by
treatment with BFA or ilimaquinone. The labeled A chain
underwent retrograde transport to the ER where it be-
came core glycosylated, and then translocated to the cyto-
sol. Only free glycosylated A chain entered the cytosol, in-
dicating that transport to the ER was a prerequisite for
translocation. At this stage it is unclear whether the A and
B chains dissociate in the ER before translocation, or in
the cytosol after translocation of the holotoxin. A similar
experimental approach has confirmed that ST B fragment
also reaches the ER via the Golgi apparatus (13).
 
Do Toxins Use the ER-associated Protein Degradation 
Pathway to Enter the Cytosol?
 
It has been known for some time that small glycopeptides
can enter the cytosol directly from the ER (30), and more
recently it has become apparent that proteins and glyco-
proteins also do so as part of the ER quality control func-
tion (14). Nascent secretory proteins enter the ER through
a proteinaceous channel whose central component is
Sec61p, the Sec61p translocon. Only if secretory proteins
are folded correctly, and if appropriate, correctly assem-
bled into oligomers, are they packaged into ER–Golgi
transport vesicles. Proteins that fail to fold or assemble
properly are instead exported across the ER membrane to
the cytosol, where they are degraded by the proteasomes
(10, 47). Human cytomegalovirus (CMV) takes advantage
of this export machinery to downregulate antigen presen-
tation at the cell surface by the class I major histocompati-
bility complex (MHC). CMV proteins in the ER cause dis-
location of the transmembrane MHC class 1 heavy chain
from the ER membrane to the cytosol, and its subsequent
degradation by the proteasomes (48, 49). Genetic and bio-
chemical experiments in 
 
Saccharomyces cerevisiae
 
 demon-
strated that soluble, misfolded proteins are also exported
across the ER membrane to the cytosol for degradation
(10, 19). Coimmunoprecipitation studies indicated that the
MHC class 1 heavy chain in CMV-infected cells might be
exported through the Sec61p translocon (49). Direct evi-
dence for the involvement of Sec61p in the export of mis-
folded proteins from the ER to the cytosol has recently
been demonstrated in yeast (26, 27). It is likely that when
toxins such as PE, ST, or ricin reach the ER lumen, thiol
exchange catalyzed by protein disulfide isomerase causes
dissociation of the disulfide-linked A and B subunits. Re-
ductive dissociation in the oxidizing environment of the
ER lumen has been demonstrated for disulfide-linked
cholera toxin A fragments (23). Dissociation of the toxin
subunits exposes a hydrophobic region present in the A
polypeptides that may promote unfolding or membrane
interaction. In the case of ricin A chain, point mutations in
this region do not affect catalytic activity but dramatically
reduce ricin cytotoxicity, which may indicate that the hy-
drophobic stretch plays some role in the membrane trans-
location step (39). The free A subunits may be perceived
as unassembled polypeptides or—if ER resident chaper-
ones cause partial unfolding—as misfolded polypeptides.
Evidence that both DT A and ricin A chain partially un-
fold during cell entry has been presented (1, 6). This may
result in export to the cytosol by the ER quality control
system. If this is the case, some of the exported toxin must
avoid proteasomal degradation and assume its biologically
active conformation in order to kill the cell. An in vitro
study has reported that the NH
 
2
 
-terminal region of the
translocated PE fragment promotes its own export after
microsomal membrane insertion (41).
 
Summary and Future Prospects
 
Bacterial and plant toxins that kill mammalian cells by
modifying intracellular targets are unusual in that they
both fold and traverse a membrane twice. They cross a
membrane and fold for the first time as they are secreted
from the producing bacteria or enter the ER lumen of the
eukaryotic plant cells. During the intoxication process, the
toxin A subunits partially unfold and again cross a mem-
brane before refolding in the cytosol. Whereas some tox-
ins, including DT, take advantage of the low pH to cross
the endosomal membrane, others such as PE, ST, and ricin
are apparently unable to form or become part of a translo-
cation channel. Therefore, these toxins undergo retrograde
transport through the secretory pathway to reach a cellu-
lar compartment where protein-conducting channels are
already present—the ER. This is achieved by parasitizing
normal cellular components that recycle between the plasma
membrane and the TGN, and between the TGN and the
ER. From the ER, the toxins enter the cytosol, possibly via
the Sec61p translocon, and perhaps by masquerading as
substrates for the ER export machinery. It may be possible
to take advantage of the ability of these toxins to reach the
ER. For example, toxins may be able to directly deliver
antigenic peptides to MHC class 1 molecules. Finally, toxin
entry demonstrates that the eukaryotic secretory pathway
is completely reversible. This is physiologically significant
in that it provides a route by which these exogenous pro-
teins reach their cytosolic targets.
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